upcoming events

USJMF & USJMF Affiliated Events

Wilson Sonsini Supports From The Innovator's Workbench

Erica Rodgers, Leslie Trigg, and Bess Weatherman have a few things in common. They are health tech leaders known for vision, commitment, and audacity. They were the driving force behind two major IPOs last year. And they are role models for aspiring innovators everywhere.

Join us for a conversation led by David Cassak, co-editor-in-chief of MedTech Strategist, to hear about their successes, lessons learned, and what they think will matter most in 2021.

Date: March 3, 2021
Time: 5:00 - 6:30 PM PST

Registration Link: http://bit.ly/IWB_Mar3

Products, Partners & Public Health: How Your Organization Can Work with the
National Institutes of Health Zoom Call by MedTech Frontiers

Date: Thursday, March 4, 2021
Time: 12pm-1:15pm
Location: A custom Zoom link will be emailed to each registrant
Speaker: Steven M. Ferguson, CLP
Special Advisor: Office of Technology Transfer and National Institutes of Health

Please register no later than 10:00AM the day of the event.

Happy almost-Spring, and greetings to our MTF community. While we miss seeing you, we hope that you and your loved ones continue to be safe and well. Please know that we appreciate your support over the years, and look forward to seeing you again. Thanks to those of you who have joined our recent MTF events via our "new" Zoom format.

About the Seminar:

The United States currently leads the world in government support for non-military research and development (R&D), especially support for work that directly relates to health and human development. A focal point for such investments to date in biomedical research has been the National Institutes of Health (NIH), receiving approximately $41.7 billion in fiscal year 2020. Approximately 9% of this funding is spent annually on internal R&D projects (intramural research) utilizing the work of about 9,000 scientists. The other funding is largely utilized to support the work of 35,000 non-government investigators (extramural research) at various colleges and universities in the U.S. and abroad as well as corporate research undertaken at small businesses.

Whether internal or externally based, the biomedical research performed has led to a large variety of novel basic and clinical research discoveries - all of which generally require commercial partners in order to develop them into products for hospital, physician or patient use. Thus, the NIH needs and actively seeks partners and licensees to help develop and commercialize its research into products to help fulfill its mission as a healthcare agency.

The presentation will examine how the NIH technology transfer program works to meet these goals as well as offering suggestions and practical advice for organizations seeking new product ideas or looking to interact with NIH scientists in order to start or expand their businesses. With over 700 products from these license agreements currently on the market, licensing, collaboration, funding or contract activities with NIH cannot be overlooked as part of growth strategies for biomedical firms.

MedTech Frontiers is a continuing series of free events for medical device and life science investors, entrepreneurs, clinicians, and technologists. We have hosted over 100 talks to foster innovation, community, and learn about emerging technologies beyond our labs. Please join us for learning, conversation, networking, and presentations by Silicon Valley luminaries held on the first Thursday of each month. Events are free, but registration is requested for planning purposes.

Questions or comments? Feel free to email us: mtf@tripleringtech.com

REGISTER: https://events.r20.constantcontact.com/register/eventReg?c=&ch=&oeidk=a07ehmmgzk923eae4f9&oseq

Kansai Life Science Accelerator Pitch Demo Day

Are you interested in learning about Japanese life science startup companies? Join us and meet the innovative six companies, part of the Kansai Life Science Accelerator Program. The startups will present their business plans, seeking financial and/or business partners in the global market.

The Kansai Life Science Accelerator Program is a new mentoring program for life science startups in Japan that was launched in 2020 to establish Japanese-American partnerships between startups and the pharma industry in California.

The program aims to nurture and support startup entrepreneurs and managers, and build up the life science ecosystems of Kobe and the Kansai region. The Japanese companies gain introductions through the CLSI network to the silicon valley life sciences community.

Have questions? Email Shikha Sharma at ssharma@califesciences.org

REGISTRATION: https://hopin.com/events/kansai-demo-day?utm_campaign=CLSI%20FAST&utm_medium=email&_hsenc=p2ANqtz-8NTc_E78uxy5sUzYl5QLA5AqaZT2duob52Qv6ZPHbd0TuZolPY9OWJiffM7cD7XW-n09ivd8W0T2m-Dr4TLN5CpGkLOmaaYWKBdNWZX79mARIyOZ0&_hsmi=112747351&utm_content=112747351&utm_source=hs_email&hsCtaTracking=b95e0262-ff55-4591-9d31-164408189c7b%7C6da984a7-0b4f-4da8-8323-bed5df320418

2021 Bay Area BioMedical Device Conference

​​The 2021 Bay Area Biomedical Device Conference will be held on Tuesday and Wednesday, March 30-31, 2021 from 8:00 a.m. to 1:00 p.m. on both days.

​​The Conference will be held virtually through Gatherly; more information about how to access and use Gatherly will be available soon


  • Facebook
  • LinkedIn

© 2020 US-Japan Medtech Frontiers

USJMF Wide shot.png